Properties (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
2014
|
| gptkbp:awards |
various industry awards
|
| gptkbp:communityEngagement |
educational programs
volunteer initiatives health awareness campaigns partnerships with NGOs donations to health causes |
| gptkbp:employees |
over 10,000
|
| gptkbp:focusArea |
antibiotics
oncology drugs cardiovascular drugs respiratory drugs women's health products diabetes medications gastrointestinal drugs pain management drugs neurology drugs dermatology drugs |
| gptkbp:founded |
1961
|
| gptkbp:founder |
B._S._Sethi
|
| gptkbp:headquarters |
gptkb:London,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ranbaxy (UK) Limited
|
| gptkbp:innovation |
supply chain optimization
digital health solutions advanced manufacturing processes telemedicine initiatives data analytics in healthcare AI in drug discovery new drug formulations patient-centric approaches biologics_development |
| gptkbp:market |
global
|
| gptkbp:operatesIn |
over 150 countries
|
| gptkbp:parentCompany |
gptkb:Sun_Pharmaceutical_Industries
|
| gptkbp:partnerships |
various healthcare organizations
|
| gptkbp:products |
generic drugs
|
| gptkbp:regulatoryCompliance |
FDA_approved
|
| gptkbp:researchAndDevelopment |
pharmaceutical research
|
| gptkbp:researchInterest |
academic institutions
government health agencies international health organizations clinical research organizations pharmaceutical research networks |
| gptkbp:revenue |
approximately $1 billion
|
| gptkbp:socialMediaPresence |
active on Twitter
active_on_Facebook active_on_Instagram active_on_LinkedIn |
| gptkbp:subsidiary |
gptkb:Ranbaxy_Laboratories_Limited
|
| gptkbp:sustainabilityInitiatives |
ethical sourcing
community health programs environmental responsibility employee welfare programs clinical trials transparency access to medicines programs |
| gptkbp:website |
www.ranbaxy.co.uk
|